Bottom line
HCPSX vs FHLC: the short answer
HCPSX (Health Care Ultrasector Profund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 69 for HCPSX, so beyond the top names it adds exposure HCPSX doesn't have.
FHLC is cheaper at 0.084% vs 2.76% — a difference of $268 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +5.3% for HCPSX (reporting dates differ).
Updated Nov 19, 2026
HCPSX vs FHLC side by side
| HCPSX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.76% | 0.084% |
| Annual cost per $10k | $276 | $8.4 |
| 10-yr cost on $10k (prospectus) | $3,090 | $108 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −2.4% | +2.6% |
| 5-yr return (annualized) | +5.3% | +7.2% |
| 10-yr return (annualized) | +8.1% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $12.1M | $3.3B |
| Number of holdings | 69 | 337 |
| Portfolio turnover | 99% | 3% |
| Returns as of | Dec 31, 2024 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of HCPSX's top 25 holdings also appear in FHLC's top 25.
| Holding | HCPSX | FHLC |
|---|---|---|
| Eli Lilly & Company | 11.83% | 13.35% |
| Johnson & Johnson | 8.03% | 8.93% |
| Abbvie Inc | 5.77% | 6.42% |
| Unitedhealth Group Inc | 4.90% | 5.44% |
| Merck & Company Inc | 4.19% | 4.66% |
| Thermo Fisher Scientific Inc | 2.78% | 3.09% |
| Amgen Inc | 2.71% | 3.00% |
| Abbott Laboratories | 2.40% | 2.66% |
| Gilead Sciences Inc | 2.10% | 2.34% |
| Pfizer Inc | 1.86% | 2.06% |
| Bristol-myers Squibb Company | 1.74% | 1.93% |
| Cvs Health Corp | 1.73% | 1.92% |
| Intuitive Surgical Inc | 1.63% | 1.82% |
| Danaher Corp | 1.60% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.57% | 1.76% |
Source: SEC Form N-PORT
HCPSX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between HCPSX and FHLC?
Which is cheaper, HCPSX or FHLC?
Should I own both HCPSX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.